Smith et al v. Johnson & Johnson et al, No. 2:2012cv01498 - Document 81 (S.D.W. Va. 2017)
Court Description: MEMORANDUM OPINION AND ORDER (Daubert Motion re: William Boykin, M.D.) The 62 MOTION by Ethicon, Inc., Johnson & Johnson to Exclude the Testimony of William Boykin, M.D. is GRANTED in part and RESERVED in part, as more fully set forth herein. Signed by Judge Robert C. Chambers on 12/12/2017. (cc: counsel of record; any unrepresented party) (ts)
Download PDF
<![CDATA[
Smith et al v. Johnson & Johnson et al Doc. 81 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA CHARLESTON DIVISION MARK SMITH, Administrator and Personal Representative of Estate of PATRICIA G. SMITH, et al., Plaintiffs, v. CIVIL ACTION NO. 2:12-cv-01498 ETHICON, INC., et al., Defendants. MEMORANDUM OPINION AND ORDER (Daubert Motion re: William Boykin, M.D.) Pending before the court is the Motion to Exclude the Testimony of William Boykin, M.D. [ECF No. 62] filed by the defendants. The Motion is now ripe for consideration because briefing is complete. I. Background This case resides in one of seven MDLs assigned to the Honorable Joseph R. Goodwin by the Judicial Panel on Multidistrict Litigation concerning the use of transvaginal surgical mesh to treat pelvic organ prolapse (“POP”) and stress urinary incontinence (“SUI”). This individual case is one of a group of cases that the Clerk of the Court reassigned to me on November 22, 2016. [ECF No. 123]. In the seven MDLs, there are approximately 28,000 cases currently pending, approximately 17,000 of which are in the Ethicon MDL, MDL 2327. Dockets.Justia.com Prior to the reassignment, in an effort to efficiently and effectively manage the massive Ethicon MDL, Judge Goodwin decided to conduct pretrial discovery and motions practice on an individualized basis so that once a case is trial-ready (that is, after the court has ruled on all summary judgment motions, among other things), it can then be promptly transferred or remanded to the appropriate district for trial. To this end, Judge Goodwin ordered the plaintiffs and defendants to submit a joint list of 200 of the oldest cases in the Ethicon MDL that name only Ethicon, Inc., Ethicon, LLC, and/or Johnson & Johnson. These cases became part of a “wave” of cases to be prepared for trial and, if necessary, remanded. See Pretrial Order No. 206, In re Ethicon, Inc. Pelvic Repair Sys. Prods. Liab. Litig., No. 2:12-md-02327, Nov. 20, 2015, http://www.wvsd.uscourts.gov/MDL/ethicon/orders.html. The plaintiff’s case was selected as an “Ethicon Wave 2 case.” II. Legal Standard By now, the parties should be intimately familiar with Rule 702 of the Federal Rules of Evidence and Daubert, so the court will not linger for long on these standards. Expert testimony is admissible if the expert is qualified and if his or her expert testimony is reliable and relevant. Fed. R. Evid. 702; see also Daubert, 509 U.S. at 597. An expert may be qualified to offer expert testimony based on his or her “knowledge, skill, experience, training, or education.” Fed. R. Evid. 702. Reliability may turn on the consideration of several factors: (1) whether a theory or technique can be or has been tested; (2) whether it has been subjected to peer review and 2 publication; (3) whether a technique has a high known or potential rate of error and whether there are standards controlling its operation; and (4) whether the theory or technique enjoys general acceptance within a relevant scientific community. Cooper v. Smith & Nephew, Inc., 259 F.3d 194, 199 (4th Cir. 2001) (citing Daubert, 509 U.S. at 592–94). But these factors are neither necessary to nor determinative of reliability in all cases; the inquiry is flexible and puts “principles and methodology” above conclusions and outcomes. Daubert, 509 U.S. at 595; see also Kumho Tire Co. v. Carmichael, 525 U.S. 137, 141, 150 (1999). Finally, and simply, relevance turns on whether the expert testimony relates to any issues in the case. See, e.g., Daubert, 509 U.S. at 591–92 (discussing relevance and helpfulness). In the context of specific causation expert opinions, the Fourth Circuit has held that “a reliable differential diagnosis provides a valid foundation for an expert opinion.” Westberry v. Gislaved Gummi AB, 178 F.3d 257, 263 (4th Cir. 1999). A reliable differential diagnosis typically, though not invariably, is performed after ‘physical examinations, the taking of medical histories, and the review of clinical tests, including laboratory tests,’ and generally is accomplished by determining the possible causes for the patient’s symptoms and then eliminating each of these potential causes until reaching one that cannot be ruled out or determining which of those that cannot be excluded is the most likely. Id. at 262 (citations omitted). “A differential diagnosis that fails to take serious account of other potential causes may be so lacking that it cannot provide a reliable basis for an opinion on causation.” Id. at 265. However, an expert’s causation opinions will not be excluded “because he or she has failed to rule out every possible alternative 3 cause of a plaintiff's illness.” Id. “The alternative causes suggested by a defendant ‘affect the weight that the jury should give the expert’s testimony and not the admissibility of that testimony,’ unless the expert can offer ‘no explanation for why she has concluded [an alternative cause offered by the opposing party] was not the sole cause.’” Id. at 265 (citations omitted). At bottom, the court has broad discretion to determine whether expert testimony should be admitted or excluded. Cooper, 259 F.3d at 200. III. Discussion Ethicon argues that I should exclude numerous portions of Dr. Boykin’s testimony that fall outside the scope of his treatment of Ms. Smith because he is a non-retained treating physician. Although parties need not disclose non-retained treating physicians where that physician intends to testify regarding “knowledge gained and opinions formed during the course of treatment” non-retained treating physicians do not have cart blanche to provide wide-ranging expert testimony. In re C. R. Bard, Inc., 948 F. Supp. 2d 589, 615 (S.D. W. Va. 2013), on reconsideration in part (June 14, 2013). Where “treating physicians offer opinions formed outside the course of treatment,” their testimony must be excluded. Id. at 616. Dr. Boykin’s broad testimony includes opinions about the TVT-O’s properties and other general causation issues. To the extent Ethicon seeks to exclude Dr. Boykin’s testimony beyond the scope of his treatment of Ms. Smith, its Motion is GRANTED, and any remaining issues are RESERVED for trial. 4 IV. Conclusion The court ORDERS that the Motion to Exclude the Testimony of William Boykin, M.D. [ECF No. 62] is GRANTED in part and RESERVED in part. The court DIRECTS the Clerk to send a copy of this Order to counsel of record and any unrepresented party. ENTER: December 12, 2017 ROBERT C. CHAMBERS UNITED STATES DISTRICT JUDGE 5
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
